These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 16443262)
1. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262 [TBL] [Abstract][Full Text] [Related]
2. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer]. Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631 [TBL] [Abstract][Full Text] [Related]
4. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598 [TBL] [Abstract][Full Text] [Related]
5. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer]. Ma Y; Peng ZL Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894 [TBL] [Abstract][Full Text] [Related]
6. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566 [TBL] [Abstract][Full Text] [Related]
8. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression. Crasta JA; Mishra S; Vallikad E Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585 [TBL] [Abstract][Full Text] [Related]
9. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
10. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475 [TBL] [Abstract][Full Text] [Related]
11. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829 [TBL] [Abstract][Full Text] [Related]
12. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer. Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677 [TBL] [Abstract][Full Text] [Related]
14. Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Klasa-Mazurkiewicz D; Narkiewicz J; Milczek T; Lipińska B; Emerich J Gynecol Oncol; 2009 Apr; 113(1):91-8. PubMed ID: 19193429 [TBL] [Abstract][Full Text] [Related]
15. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Sopel M; Surowiak P; Berdowska I Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806 [TBL] [Abstract][Full Text] [Related]
16. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178 [TBL] [Abstract][Full Text] [Related]
17. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489 [TBL] [Abstract][Full Text] [Related]
19. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome. Shi L; Chen XM; Wang L; Zhang L; Chen Z Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]